Literature DB >> 2428783

Fine specificity of human HLA-B7-specific cytotoxic T-lymphocyte clones. I. Identification of HLA-B7 subtypes and histotopes of the HLA-B7 cross-reacting group.

G A van Seventer, B Huis, C J Melief, P Iványi.   

Abstract

Three HLA-B7-specific cytotoxic T lymphocyte (CTL) clones are described. Their fine specificity is examined by extensive panel and family studies. Four CTL-defined subtypes of HLA-B7 could be found: HLA-B7.1, -B7.2, -B7.3, and -B7.4. Biochemical evidence was obtained in one-dimension isoelectric focusing for only two subtypes. The estimated subtype frequencies in the Caucasian population are presented. Furthermore, a linkage disequilibrium between HLA-A29 and HLA-B7.3 is suggested. The CTL clones exerted distinct "extra-reactivities", i.e., lysis of some non-B7 target cells. These extra reactivities could be assigned to the cross-reacting group of HLA-B7.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428783     DOI: 10.1016/0198-8859(86)90064-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Blood Adv       Date:  2018-12-26

2.  Serological and biochemical identification of HLA-Aw33 subtypes.

Authors:  L P de Waal; H J Mesman; C P Engelfriet
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Authors:  K D Smith; D F Epperson; C T Lutz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Authors:  Jun Zou; Stefan O Ciurea; Piyanuch Kongtim; Min Yi; Yudith Carmazzi; Gabriela Rondon; Samer Srour; David Partlow; Richard E Champlin; Kai Cao
Journal:  Blood Adv       Date:  2020-08-11

5.  Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Jun Zou; Tao Wang; Meilun He; Yung-Tsi Bolon; Shahinaz M Gadalla; Steven G E Marsh; Michelle Kuxhausen; Robert Peter Gale; Akshay Sharma; Amer Assal; Tim Prestidge; Mahmoud Aljurf; Jan Cerny; Sophie Paczesny; Stephen R Spellman; Stephanie J Lee; Stefan O Ciurea
Journal:  Transplant Cell Ther       Date:  2021-11-11

6.  Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation.

Authors:  G J Boland; R J Hene; C Ververs; M A de Haan; G C de Gast
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Authors:  Rene Duquesnoy; Stephen Spellman; Michael Haagenson; Tao Wang; Mary M Horowitz; Machteld Oudshoorn
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

8.  Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.

Authors:  Jun Zou; Piyanuch Kongtim; Betül Oran; Vasilis Kosmoliaptsis; Yudith Carmazzi; Junsheng Ma; Liang Li; Gabriela Rondon; Samer Srour; Hannah C Copley; David Partlow; Stefan O Ciurea; Uri Greenbaum; Qing Ma; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.